Instrument Inactif

Autres langues StemCells Inc Nasdaq

Actions

US85857R2040

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

14/08	Microbot Medical Inc. : B. Riley persiste à l'achat	ZM
11/08	Microbot Medical Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

25/09	Microbot Medical® Highlights Growth Strategy
11/08	Microbot Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
11/08	Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
11/08	Microbot Medical Inc. Announces Revenue Results for the Second Quarter Ended June 30, 2026
21/07	Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
07/07	Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026
30/06	Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader
25/06	Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
25/06	Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
23/06	Microbot Medical Announces First Health System in Pennsylvania to Adopt the Liberty Endovascular Robotic System
23/06	Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System
17/06	Microbot Medical Enters into an Agreement to Expand Access for America's Veteran and Military Patient Populations
16/06	Microbot Medical Inc. Enters Into Agreement With Lovell Government Services To Expand Access For America?s Veteran And Military Patient Populations
16/06	Microbot Medical Enters Agreement Expanding Access to Federal Healthcare Systems
16/06	Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
09/06	Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
09/06	Microbot Medical Inc. Announces A Notable Health System as the First in Michigan to Adopt the Liberty Endovascular Robotic System
02/06	Microbot Medical Inc. Secures First North Carolina Healthcare System to Adopt the LIBERTY Endovascular Robotic System
02/06	Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
26/05	Microbot Medical Inc. Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY Endovascular Robotic System
26/05	Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
15/05	Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
14/05	Microbot Medical recorded revenue during its quarter ended March 31, benefiting from limited market release of Liberty System
14/05	Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
13/05	Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026